Pharmacokinetics of meropenem during advanced organ support (ADVOS®) and continuous renal replacement therapy

Related Research units

Abstract

The advanced organ support (ADVOS) system allows to eliminate water-soluble as well as protein-bound molecules. Despite its clinical features, to date nothing is known about the elimination of clinically relevant drugs such as antiinfectives. Therefore, we report a case treated with ADVOS, continuous renal replacement therapy (CRRT), and meropenem (1 g 8-hourly) for empiric sepsis therapy monitored by meropenem drug levels. ADVOS showed more efficient elimination of meropenem compared to CRRT which has to be considered when evaluating dosing regimens.

Bibliographical data

Original languageEnglish
ISSN0391-3988
DOIs
Publication statusPublished - 10.2021
PubMed 34144656